Browse studies

Find your next paid study

27,273 recruiting studies available now

A Randomized, Double-blind, Placebo-controlled Extension Study, Followed by a Study Treatment Withdrawal or Open-label Period, to Assess the Long-term Safety and Tolerability of Ianalumab in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE Extension)

The purpose of this study is to evaluate long-term safety and tolerability of ianalumab in participants with systemic lupus erythematosus who have previously c…

Systemic Lupus Erythematosus

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT06133972

Observational

Development of Neuroimaging Methods to Assess the Neurobiology of Addiction

Background: Abusing alcohol, drugs, and other substances can cause serious health problems. These substances also can affect brain function. Researchers want …

Normal Physiology

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT02535702

Observational

Exploring the Parameter Space of High Frequency Magnetic Perturbation in Manipulating Neural Excitability and Plasticity.

The investigators have recently developed a new non-invasive brain stimulation (NIBS) system, kilohertz transcranial magnetic perturbation (kTMP) that opens up…

Healthy

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Magnetic TidesNCT05959031

Phase 2

Ranolazine in ALS: Safety, and Effect on Cramps, Function and Quality of Life.

The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS.

Amyotrophic Lateral Sclerosis

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Swathy Chandrashekhar, MBBSNCT06527222

Phase 1

A Phase 1/2, First-in-human, Double-blind, Placebo-controlled Study to Assess Dose, Safety, and Efficacy of UX016 (Sialic Acid-C16 Prodrug) in Adults With GNE Myopathy

The goal of this study is to assess the safety and dose of UX016 and its impact on muscle strength in adults with GNE Myopathy (GNEM).

GNE Myopathy

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Ultragenyx Pharmaceutical IncNCT07511556

Phase 4

Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors

The purpose of this study is to find out if taking a Fisetin supplement can decrease fatigue among older cancer survivors.

Fatigue

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT06819254

Observational

Preventing Overdose in Supportive Housing: Stepped Wedge Randomized Controlled Trial of a Multi-Sector, Upstream Intervention

This community-partnered study examines a technical assistance intervention designed to help permanent supportive housing agencies implement evidence-based pra…

OverdoseSubstance Use

Estimated

~$10 – $1,125

Actual pay is set by the research site.

NYU Langone HealthNCT07214519

Observational

Effects of Respiratory Muscle Training and Aerobic Exercise on Lung Health in Smokers: A Pilot Parallel-Group Study for Lung Cancer Prevention

This clinical trial studies whether home-based respiratory muscle training (RMT) and aerobic exercise (AE) programs can be used to improve lung health in curre…

Lung Carcinoma

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Roswell Park Cancer InstituteNCT07553819

Phase 2

A Phase 2 Open-label Basket Study to Evaluate the Efficacy and Safety of Orally Administered Reversible Tyrosine Kinase Inhibitor BAY 2927088 in Participants With Metastatic or Unresectable Solid Tumors With HER2-activating Mutations

Researchers are looking for a better way to treat people who have solid tumors with HER2-activating mutations. Before a treatment can be approved for people to…

Advanced Solid TumorsHER2 Mutation

Estimated

~$75 – $3,000

Actual pay is set by the research site.

BayerNCT06760819

Phase 1

A Randomized, Open-label Clinical Trial to Assess the Safety, Feasibility and Immunogenicity of Adjuvant PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients

A Feasibility Trial of PVX7 vaccine in advanced cervical cancer patients who have completed primary definitive therapy.

Cervical Cancer

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT06315257

Phase 2

A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants

The purpose of this study is to evaluate the efficacy and safety of the study drug, Corabotase (also known as IPN10200), and to assess how well it works when c…

Cervical Dystonia

Estimated

~$75 – $3,000

Actual pay is set by the research site.

IpsenNCT06937931

Observational

The Impact of an Intervention to Reduce Pharmacists' Racial Bias Towards People of Color at Risk of HIV

This study will follow the ADAPT-ITT model to apply the Prejudice Habit Breaking Intervention (PHBI) to pharmacists who have experience with or are willing to …

Bias, ImplicitHIVPre-exposure Prophylaxis

Estimated

~$10 – $750

Actual pay is set by the research site.

Massachusetts General HospitalNCT06487351